Investor Boxer Capital, LLC
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Boxer Capital, LLC . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-10-15 13D/A TYRA / Tyra Biosciences, Inc. 6,448,359 6,534,298
2024-10-15 13D/A ITOS / iTeos Therapeutics, Inc. 2,946,915 3,020,052
2024-10-15 13D/A TNGX / Tango Therapeutics, Inc. 8,339,935
2024-09-27 13G TIL / Instil Bio, Inc. 355,500
2024-07-18 13G QURE / uniQure N.V. 2,500,000
2024-05-14 13D/A ITOS / iTeos Therapeutics, Inc. 2,154,058 2,946,915
2024-04-22 13G IPSC / Century Therapeutics, Inc. 4,901,603
2024-02-14 13G/A PMVP / PMV Pharmaceuticals, Inc. 3,163,795 0
2024-02-12 13G FATE / Fate Therapeutics, Inc. 6,171,000
2024-02-08 13D/A TYRA / Tyra Biosciences, Inc. 6,323,359 6,448,359
2024-01-25 13D/A MRTX / Mirati Therapeutics, Inc. 11,661,726 0
2024-01-18 13G NKTX / Nkarta, Inc. 4,407,350
2023-12-18 13D/A RAIN / Rain Enhancement Technologies Holdco, Inc. 2,815,562 2,933,152
2023-10-12 13D/A MRTX / Mirati Therapeutics, Inc. 11,661,726 11,661,726
2023-08-16 13D/A MRTX / Mirati Therapeutics, Inc. 10,290,847 11,661,726
2023-05-25 13D/A RAIN / Rain Enhancement Technologies Holdco, Inc. 2,510,127 2,815,562
2023-02-14 13G/A MIST / Milestone Pharmaceuticals Inc. 2,238,861 698,861
2023-02-14 13G/A IDYA / IDEAYA Biosciences, Inc. 2,202,812 2,202,812
2023-02-14 13G/A PMVP / PMV Pharmaceuticals, Inc. 2,838,236 3,163,795
2022-11-08 13D/A RAIN / Rain Enhancement Technologies Holdco, Inc. 1,894,192 2,510,127
2022-09-19 13G SWTX / SpringWorks Therapeutics, Inc. 3,421,541
2022-06-16 13D/A TYRA / Tyra Biosciences, Inc. 6,323,359 6,323,359
2022-05-11 13D/A ITOS / iTeos Therapeutics, Inc. 3,142,058 2,154,058
2022-03-21 13D/A ITOS / iTeos Therapeutics, Inc. 3,717,259 3,142,058
2022-02-14 13G/A MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock) 10,309,250 4,082,576
2022-02-14 13G/A FSTX / F-star Therapeutics Inc 1,501,428 0
2022-02-14 13G/A SBTX / Silverback Therapeutics Inc 1,675,377 0
2022-02-14 13G/A MIST / Milestone Pharmaceuticals Inc. 2,477,194 2,238,861
2022-02-14 13G/A SLDB / Solid Biosciences Inc. 6,200,261 5,336,031
2022-02-14 13G/A BCEL / Atreca, Inc. 2,202,333 2,202,333
2022-02-14 13G/A ELEV / Elevation Oncology, Inc. 1,341,530 872,780
2022-02-14 13G/A MTNB / Matinas BioPharma Holdings, Inc. 11,478,634 0
2022-02-14 13G/A CABA / Cabaletta Bio, Inc. 1,603,361 540,000
2022-02-14 13G/A MRNS / Marinus Pharmaceuticals, Inc. 4,800,000 0
2022-02-14 13G/A CBAY / CymaBay Therapeutics, Inc. 4,000,000 0
2022-02-14 13G/A DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 3,767,299 1,067,299
2022-02-14 13G/A / Therapeutics Acquisition Corp. Class A 1,500,000 2,500,000
2022-02-14 13G/A TLIS / Talis Biomedical Corporation 1,550,998 0
2022-02-14 13G/A PMVP / PMV Pharmaceuticals, Inc. 2,268,236 2,838,236
2022-02-14 13G/A BMEA / Biomea Fusion, Inc. 2,088,405 1,188,405
2022-02-14 13G/A MRUS / Merus N.V. 1,600,000 1,900,000
2022-01-06 13D/A ITOS / iTeos Therapeutics, Inc. 4,345,016 3,717,259
2021-11-26 13D/A ODT / Odonate Therapeutics Inc 4,607,086 4,207,086
2021-11-22 13D/A ODT / Odonate Therapeutics Inc 4,766,886 4,607,086
2021-09-24 13D TYRA / Tyra Biosciences, Inc. 6,323,359
2021-07-09 13G ELEV / Elevation Oncology, Inc. 1,341,530
2021-05-17 13G FSTX / F-star Therapeutics Inc 1,501,428
2021-05-03 13D RAIN / Rain Enhancement Technologies Holdco, Inc. 1,894,192
2021-04-30 13G BMEA / Biomea Fusion, Inc. 2,088,405
2021-02-26 13G TLIS / Talis Biomedical Corporation 1,550,998
2021-02-16 13G/A CLRB / Cellectar Biosciences, Inc. 931,764 1,840,000
2021-02-16 13G/A BLCM / Bellicum Pharmaceuticals, Inc. 5,133,600 265,743
2021-02-16 13G/A MIST / Milestone Pharmaceuticals Inc. 1,777,194 2,477,194
2021-02-16 13G/A BCEL / Atreca, Inc. 1,733,583 2,202,333
2021-02-16 13G/A CABA / Cabaletta Bio, Inc. 1,566,361 1,603,361
2021-02-16 13G/A TRIL / Trillium Therapeutics Inc 4,425,000 0
2021-02-16 13G/A SLDB / Solid Biosciences Inc. 3,201,689 6,200,261
2021-02-16 13G/A MTNB / Matinas BioPharma Holdings, Inc. 10,188,312 11,478,634
2021-02-16 13G/A RVMD / Revolution Medicines, Inc. 3,259,764 3,309,264
2021-02-16 13G/A DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 3,192,299 3,767,299
2021-02-16 13G/A RCUS / Arcus Biosciences, Inc. 3,022,391 2,084,883
2021-02-16 13G/A MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock) 20,361,875 10,309,250
2021-02-16 13G/A SNDX / Syndax Pharmaceuticals, Inc. 2,763,569 2,358,005
2021-01-20 13G MRUS / Merus N.V. 1,600,000
2020-12-18 13G/A SBTX / Silverback Therapeutics Inc 1,675,374 1,675,377
2020-12-17 13G SBTX / Silverback Therapeutics Inc 1,675,374
2020-11-02 13D/A MRTX / Mirati Therapeutics, Inc. 10,290,847 10,290,847
2020-10-31 13D/A MRTX / Mirati Therapeutics, Inc. 8,768,283 10,290,847
2020-09-30 13G PMVP / PMV Pharmaceuticals, Inc. 2,268,236
2020-09-24 13G CBAY / CymaBay Therapeutics, Inc. 4,000,000
2020-09-01 13D/A ODT / Odonate Therapeutics Inc 2,978,762 4,766,886
2020-08-07 13D ITOS / iTeos Therapeutics, Inc. 4,345,016
2020-08-03 13G MIST / Milestone Pharmaceuticals Inc. 1,777,194
2020-07-30 13D / Pandion Therapeutics Inc 2,107,513
2020-07-20 13G / Therapeutics Acquisition Corp. Class A 1,500,000
2020-06-30 13G IDYA / IDEAYA Biosciences, Inc. 2,202,812 2,202,812
2020-06-29 13G IDYA / IDEAYA Biosciences, Inc. 2,202,812
2020-06-05 13G/A MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock) 12,252,715 20,361,875
2020-05-11 13G SNDX / Syndax Pharmaceuticals, Inc. 2,763,569
2020-03-02 13G MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock) 12,252,715
2020-02-14 13G/A DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 3,192,299 3,192,299
2020-02-14 13G/A RVMD / Revolution Medicines, Inc. 3,159,764 3,259,764
2020-02-14 13G/A WVE / Wave Life Sciences Ltd. 1,650,000 0
2020-02-14 13D/A MRTX / Mirati Therapeutics, Inc. 7,598,283 8,768,283
2020-02-14 13G/A MDCO / Medicines Company 4,010,742 967,000
2020-02-14 13G/A CABA / Cabaletta Bio, Inc. 1,566,361 1,566,361
2020-02-14 13G/A MTNB / Matinas BioPharma Holdings, Inc. 5,642,858 10,188,312
2020-02-14 13G/A SLDB / Solid Biosciences Inc. 3,934,760 3,201,689
2020-02-14 13G/A BCEL / Atreca, Inc. 1,733,583
2020-02-14 13G/A ESPR / Esperion Therapeutics, Inc. 1,764,649 975,100
2020-02-14 13G/A RCKT / Rocket Pharmaceuticals, Inc. 1,966,051 1,466,051
2020-02-13 13G RVMD / Revolution Medicines, Inc. 3,159,764
2020-02-13 13G RCUS / Arcus Biosciences, Inc. 3,022,391
2020-02-13 13G BDTX / Black Diamond Therapeutics, Inc. 2,014,858
2020-02-03 13G TRIL / Trillium Therapeutics Inc 4,425,000
2019-12-13 13G MRNS / Marinus Pharmaceuticals, Inc. 4,800,000
2019-11-07 13G CABA / Cabaletta Bio, Inc. 1,566,361
2019-10-11 13G/A DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 2,250,000 3,192,299
2019-08-26 13G BLCM / Bellicum Pharmaceuticals, Inc. 5,133,600
2019-07-19 13D/A MRTX / Mirati Therapeutics, Inc. 6,964,926 7,598,283
2019-07-01 13G BCEL / Atreca, Inc. 1,733,583
2019-05-28 13G CLRB / Cellectar Biosciences, Inc. 931,764
2019-05-24 13D/A MRTX / Mirati Therapeutics, Inc. 4,785,170 6,964,926
2019-03-06 13G/A SLDB / Solid Biosciences Inc. 3,509,760 3,934,760
2019-02-14 13G/A VKTX / Viking Therapeutics, Inc. 3,000,000 0
2019-02-14 13G/A SLDB / Solid Biosciences Inc. 2,525,198 3,509,760
2019-02-14 13G/A DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 2,250,000 2,250,000
2019-02-14 13G/A MGNX / MacroGenics, Inc. 2,987,260 3,815
2019-02-14 13G/A PTCT / PTC Therapeutics, Inc. 2,687,330 2,155,000
2019-02-14 13G/A ESPR / Esperion Therapeutics, Inc. 2,772,350 1,764,649
2019-02-14 13G/A 867328601 / Sunesis Pharmaceuticals, Inc. 2,125,000 0
2019-02-14 13G/A ARDM / Aradigm Corp. 1,000,000 0
2019-02-14 13G/A RCKT / Rocket Pharmaceuticals, Inc. 1,966,051
2019-02-14 13G/A WVE / Wave Life Sciences Ltd. 1,590,600 1,650,000
2019-02-14 13G/A MDCO / Medicines Company 3,825,202 4,010,742
2019-02-14 13G/A GTXO / GTX Corp 1,310,000 0
2019-02-14 13G/A MTNB / Matinas BioPharma Holdings, Inc. 7,142,858 5,642,858
2018-12-31 13G DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 2,250,000
2018-12-27 13D/A ODT / Odonate Therapeutics Inc 2,978,762
2018-11-08 13G MTNB / Matinas BioPharma Holdings, Inc. 7,142,858
2018-10-30 13G/A ESPR / Esperion Therapeutics, Inc. 2,575,000 2,772,350
2018-06-29 13G WVE / Wave Life Sciences Ltd. 1,590,600
2018-06-15 13G/A SLDB / Solid Biosciences Inc. 2,200,000 2,525,198
2018-05-18 13G SLDB / Solid Biosciences Inc. 2,200,000
2018-05-11 13G ESPR / Esperion Therapeutics, Inc. 800,000 2,575,000
2018-04-23 13G RIGL / Rigel Pharmaceuticals, Inc. 3,771,000
2018-03-05 13G 867328601 / Sunesis Pharmaceuticals, Inc. 2,125,000
2018-02-26 13G/A PTCT / PTC Therapeutics, Inc. 2,500,000 2,687,330
2018-02-20 13G GTXO / GTX Corp 1,310,000
2018-02-14 13G/A BLPH / Bellerophon Therapeutics, Inc. 1,857,143 2,800,547
2018-02-14 13G/A MGNX / MacroGenics, Inc. 2,523,223 2,987,260
2018-02-14 13G/A MDCO / Medicines Company 5,732,599 3,825,202
2018-02-14 13G/A ESPR / Esperion Therapeutics, Inc. 1,540,000 800,000
2018-02-14 13G/A ARDM / Aradigm Corp. 900,000 1,000,000
2018-02-12 13G VKTX / Viking Therapeutics, Inc. 3,000,000
2018-01-26 13G PTCT / PTC Therapeutics, Inc. 2,500,000
2018-01-19 13G RCKT / Rocket Pharmaceuticals, Inc. 1,741,051
2018-01-19 13G RCKT / Rocket Pharmaceuticals, Inc. 1,741,051
2017-12-11 13G ARDM / Aradigm Corp. 634,708 900,000
2017-12-08 13D ODT / Odonate Therapeutics Inc 2,726,938
2017-11-20 13D/A MRTX / Mirati Therapeutics, Inc. 4,221,239 4,785,170
2017-11-06 13G/A MGNX / MacroGenics, Inc. 1,987,000 2,523,223
2017-06-27 13D/A MRTX / Mirati Therapeutics, Inc. 4,228,665 4,221,239
2017-06-12 13G MGNX / MacroGenics, Inc. 1,987,000
2017-03-23 13G/A MDCO / Medicines Company 4,229,246 5,732,599
2017-03-23 13G ESPR / Esperion Therapeutics, Inc. 1,540,000
2017-03-01 13G BLPH / Bellerophon Therapeutics, Inc. 1,857,143
2017-02-14 13G/A SESN / Sesen Bio Inc. 0
2017-02-14 13G/A EIGR / Eiger BioPharmaceuticals, Inc. 138,331
2017-02-14 13G/A ARDM / Aradigm Corp. 1,101,513 634,708
2017-02-14 13G/A SESN / Sesen Bio Inc. 1,255,412 0
2017-02-14 13G/A EIGR / Eiger BioPharmaceuticals, Inc. 1,399,991 138,331
2017-02-14 13G/A SPHS / Sophiris Bio Inc 992,100 0
2017-01-30 13D/A MRTX / Mirati Therapeutics, Inc. 4,143,107 4,228,665
2017-01-10 13D/A MRTX / Mirati Therapeutics, Inc. 2,939,800 4,143,107
2016-11-22 13G MDCO / Medicines Company 4,229,246
2016-09-28 13D/A MRTX / Mirati Therapeutics, Inc. 2,939,800 2,939,800
2016-06-24 13D/A MRTX / Mirati Therapeutics, Inc. 2,939,800 2,939,800
2016-06-14 13G/A SESN / Sesen Bio Inc. 1,255,412
2016-06-14 13G/A SESN / Sesen Bio Inc. 2,255,572 1,255,412
2016-06-08 13D/A MRTX / Mirati Therapeutics, Inc. 2,471,702 2,939,800
2016-06-06 13G/A SESN / Sesen Bio Inc. 2,255,572
2016-06-06 13G/A SESN / Sesen Bio Inc. 1,505,572 2,255,572
2016-05-25 13G SESN / Sesen Bio Inc. 1,505,572
2016-05-25 13G SESN / Sesen Bio Inc. 1,505,572
2016-03-17 13D/A MRTX / Mirati Therapeutics, Inc. 2,570,562 2,471,702
2016-02-16 13G/A SPHS / Sophiris Bio Inc 992,100
2016-02-16 13G/A AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock) 139,899
2016-02-16 13G/A ARDM / Aradigm Corp. 1,101,513
2016-01-15 13D/A MRTX / Mirati Therapeutics, Inc. 2,735,512 2,570,562
2016-01-06 13D/A MRTX / Mirati Therapeutics, Inc. 2,735,512 2,735,512
2015-12-24 13G EIGR / Eiger BioPharmaceuticals, Inc. 1,399,991
2015-09-18 13D/A MRTX / Mirati Therapeutics, Inc. 2,735,512
2015-08-28 13G CLTX / Celsus Therapeutics 500,000
2015-02-13 13G/A LJPC / La Jolla Pharmaceutical Co. 133,848
2015-02-02 13G/A ARDM / Aradigm Corp. 1,186,109
2015-02-02 13D/A MRTX / Mirati Therapeutics, Inc. 2,764,810
2014-12-17 13G/A SPHS / Sophiris Bio Inc 1,518,613
2014-02-12 13G/A LJPC / La Jolla Pharmaceutical Co. 23,608,154
2013-11-04 13D MRTX / Mirati Therapeutics, Inc. 2,260,674
2013-09-25 13G ARDM / Aradigm Corp. 51,512,735
2013-08-26 13G SPHS / Sophiris Bio Inc 2,315,385
2013-05-30 13D ARDM / Aradigm Corp. 51,512,735
2013-02-13 13G/A ALXA / Alexza Pharmaceuticals, Inc. 806,714
2013-02-13 13G/A ARDM / Aradigm Corp. 15,706,284
2013-02-13 13G/A 662,115,966
2013-02-13 13G/A LJPC / La Jolla Pharmaceutical Co. 1,506,854
2013-02-13 13G/A ACHV / Achieve Life Sciences, Inc. 260,000
2012-02-27 13G ALXA / Alexza Pharmaceuticals, Inc. 7,772,089
2012-02-14 13G/A ARDM / Aradigm Corp. 14,574,575
2012-02-14 13G/A GNTA / Genenta Science S.p.A. - Depositary Receipt (Common Stock)
2012-02-14 13G/A LJPC / La Jolla Pharmaceutical Co. 6,789,077
2012-02-14 13G/A ACHV / Achieve Life Sciences, Inc. 629,801
2012-01-04 13G/A ALXA / Alexza Pharmaceuticals, Inc. 3,402,492